Science ❯ Biotechnology
T Cell Receptor Therapy Vaccine Research Cancer Treatment Cellular Therapies Antibody Development Cancer Vaccines Antibodies Antibody Treatments Checkpoint Inhibitors Research and Development
CAPGLO is moving toward clinical trials after optimization to harvest T cells in under an hour with a half-pint of blood.